French big pharma giant Servier has offered to buy the shares in Hungarian pharmaceuticals maker Egis creating M&A news.

BU it does not already own in a deal worth 107 billion forints ($482.83 million).

Servier is offering 28,000 forints ($130) per share, a 33 percent premium to Egis's closing share price on Monday.

Egis shares closed at 21,050 forints on Monday according to Reuters data. The Budapest bourse had earlier in the day suspended trading in the company's shares pending an extraordinary announcement from the company.

Egis posted a net profit of 2.92 billion forints for the third quarter, down 43 percent from the same quarter a year ago due to unfavourable exchange rate changes.

Related

Report: Partnering Deals and Alliances with Servier

Report: Merger and Acquisition Terms and Agreements

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter